News Image

Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™

Provided By GlobeNewswire

Last update: Oct 6, 2025

- Results published in Oxford Academic’s Military Medicine Journal -

- After up to 18 months of follow-up patients were observed to have zero infections, amputations or deaths and a high rate of patency -

Read more at globenewswire.com

HUMACYTE INC

NASDAQ:HUMA (11/7/2025, 8:00:02 PM)

After market: 1.41 +0.08 (+6.02%)

1.33

+0.02 (+1.53%)



Find more stocks in the Stock Screener

Follow ChartMill for more